The respiratory syncytial virus vaccine landscape: lessons from the graveyard and promising candidates

The global burden of disease caused by respiratory syncytial virus (RSV) is increasingly recognised, not only in infants, but also in older adults (aged ≥65 years). Advances in knowledge of the structural biology of the RSV surface fusion glycoprotein have revolutionised RSV vaccine development by p...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	The Lancet infectious diseases Ročník 18; číslo 10; s. e295 - e311
Hlavní autori:	Mazur, Natalie I, Higgins, Deborah, Nunes, Marta C, Melero, José A, Langedijk, Annefleur C, Horsley, Nicole, Buchholz, Ursula J, Openshaw, Peter J, McLellan, Jason S, Englund, Janet A, Mejias, Asuncion, Karron, Ruth A, Simões, Eric AF, Knezevic, Ivana, Ramilo, Octavio, Piedra, Pedro A, Chu, Helen Y, Falsey, Ann R, Nair, Harish, Kragten-Tabatabaie, Leyla, Greenough, Anne, Baraldi, Eugenio, Papadopoulos, Nikolaos G, Vekemans, Johan, Polack, Fernando P, Powell, Mair, Satav, Ashish, Walsh, Edward E, Stein, Renato T, Graham, Barney S, Bont, Louis J
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	United States Elsevier Ltd 01.10.2018 Elsevier B.V Elsevier Limited
Predmet:	Adults Antibodies, Monoclonal - immunology Antibodies, Viral - immunology Antigens Candidates Children Clinical trials COVID-19 vaccines Disease prevention Global Health Glycoproteins Humans Immunoglobulins Immunology Infants Infections Infectious diseases Medical research Monoclonal antibodies Mutation Nanoparticles Older people Proteins Respiratory syncytial virus Respiratory Syncytial Virus Infections - prevention & control Respiratory Syncytial Virus Vaccines - immunology Vaccine development Vaccines Viruses World Health Organization United States > US
ISSN:	1473-3099, 1474-4457, 1474-4457
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!